SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biowa who wrote (150)8/16/1999 6:41:00 PM
From: Biomaven  Read Replies (4) of 427
 
I'll have a shot. Basically I'm looking down a list of biotechs sorted by open short interest and picking out the "respectable" companies and also skipping those which are just arbitrage plays.

(In order by short interest:)
ELN
GENZ
AMGN
GILD
CHIR
ALKS
SEPR
AVIR
IDPH
BGEN
GELX
VRTX
IMNX
CLTR
ICOS
IMNR
CEPH
DURA
SANG

If you sort by short ratio, it looks like:
QGENF
VRTX
BVF
GELX
NFLD
GERN
ALKS
SANG
ARIA
GILD
ENMD
CLTR
ALGO
NPSP
GZTC
AVIR
CELG
ELN
TKTX
GENZ
IDPH
SEPR
INCY

Out of the latter if you picked a 15 stock portfolio of:

VRTX
GELX
ALKS
CLTR
NPSP
AVIR
ALGO
NPSP
AVIR
CELG
ELN
TKTX
GENZ
SEPR
INCY

I think you'd do pretty nicely over the next few years. If you want to get a bit riskier, you could throw in GERN and GZTC as well.

Of course a lot of the shorts old misguided favorites like AGPH, CNTO, NXTR (although maybe the perennial big short position there was just an arbitrage of some short) and SUGN are no more. <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext